|
Spain-TR-TR Azienda Directories
|
Azienda News:
- New Treatments for COPD: Inhalers, Surgery, and More - Healthline
Read on to learn more about existing and new treatment options for COPD (2018) Biologics and chronic obstructive pulmonary disease https: pubmed ncbi nlm nih gov 29729941
- A New Treatment for Chronic Obstructive Pulmonary Disease . . .
Chronic obstructive pulmonary disease (COPD) pharmacological therapy has advanced in recent years Combining long-acting bronchodilators and inhaled corticosteroids (ICSs) as a single-inhaler triple therapy reduces mortality in patients with COPD at high exacerbation risk (1, 2)
- 5 New Medical Breakthroughs for COPD Patients - WebMD
Researchers are working on new therapies to treat the symptoms of chronic obstructive pulmonary disease (COPD), like shortness of breath, lung inflammation, and chronic cough Some are already
- Promising cure for COPD: Is a breakthrough treatment within . . .
Looking ahead, the researchers are now planning a phase 2 trial of the treatment, which will evaluate its efficacy in a larger group of patients The trial has been approved by China’s National Medical Products Administration (NMPA), the Chinese equivalent of the U S Food and Drugs Administration (FDA) A promising future for COPD treatment
- New frontiers in the treatment of COPD - Mayo Clinic
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by shortness of breath, cough and sputum production due to both airway and parenchymal lung damage "It is increasingly recognized that patients with COPD have different phenotypes, and treatment can be tailored
- Advances in Chronic Obstructive Pulmonary Disease - PMC
Late breaking abstract—first-in-human results of bronchial rheoplasty: an endobronchial treatment for chronic bronchitis (CB) Eur Respir J 52:OA2162 (Abstr ) [Google Scholar] 84 Siddiqui FM, Diamond JM 2018 Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions Curr Opin Pulm
- Update on the pharmacological treatment of chronic . . .
Recent major advancements in the treatment of COPD patients have become available Areas covered: New data on the role of classic bronchodilators, including short-acting and long-acting beta2-agonists and anti-muscarinic antagonists, in the treatment of COPD patients are discussed Data promoting a more targeted approach to inhaled and systemic
- FDA Approves GSK’s Nucala for Chronic Obstructive Pulmonary . . .
Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells μL The FDA has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease
- COPD-Chronic Obstructive Pulmonary Disease - Harvard Health
In Chronic Obstructive Pulmonary Disease you'll find analyses of today's best treatment options including medications, pulmonary rehabilitations, and more; the 2 tests that offer the best clue to whether you have COPD; new oxygen systems that provide greater mobility and freedom; practical, no-cost ways to lessen symptoms and add lung power
|
|